[{"address1": "2625 Townsgate Road", "address2": "Suite 230", "city": "Westlake Village", "state": "CA", "zip": "91361", "country": "United States", "phone": "805 267 9889", "website": "https://www.genelux.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT Immunotherapy for treating pancreatic cancer. Genelux Corporation has a licensing agreement with ELIAS Animal Health, LLC for V-VET1, a clinical stage animal health product candidate. The company was incorporated in 2001 and is headquartered in Westlake Village, California.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas  Zindrick J.D.", "age": 64, "title": "Chairman, CEO & President", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 570990, "exercisedValue": 0, "unexercisedValue": 11528577}, {"maxAge": 1, "name": "Mr. Matthew  Pulisic M.B.A.", "age": 40, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Cappello Ph.D.", "age": 67, "title": "Chief Technical Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 213077, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean  Ryder J.D.", "age": 55, "title": "General Counsel & Corporate Secretary", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 380000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yong  Yu Ph.D.", "age": 53, "title": "Senior Vice President of Clinical Development", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 242615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Paul  Scigalla M.D., Ph.D.", "age": 79, "title": "Chief Medical Officer", "yearBorn": 1945, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ralph  Smalling B.Sc.", "age": 67, "title": "VP & Head of Regulatory Affairs", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.57, "open": 2.57, "dayLow": 2.55, "dayHigh": 2.67, "regularMarketPreviousClose": 2.57, "regularMarketOpen": 2.57, "regularMarketDayLow": 2.55, "regularMarketDayHigh": 2.67, "payoutRatio": 0.0, "beta": -0.395, "forwardPE": -2.7978725, "volume": 59626, "regularMarketVolume": 59626, "averageVolume": 260340, "averageVolume10days": 227110, "averageDailyVolume10Day": 227110, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 98899312, "fiftyTwoWeekLow": 1.6, "fiftyTwoWeekHigh": 5.885, "priceToSalesTrailing12Months": 12362.414, "fiftyDayAverage": 3.6886, "twoHundredDayAverage": 2.8293, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 60842632, "profitMargins": 0.0, "floatShares": 28162341, "sharesOutstanding": 37604300, "sharesShort": 2563786, "sharesShortPriorMonth": 2449398, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0682, "heldPercentInsiders": 0.12132, "heldPercentInstitutions": 0.12955, "shortRatio": 14.48, "shortPercentOfFloat": 0.0797, "impliedSharesOutstanding": 37604300, "bookValue": 0.766, "priceToBook": 3.4334207, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -29869000, "trailingEps": -0.95, "forwardEps": -0.94, "enterpriseToRevenue": 7605.329, "enterpriseToEbitda": -1.934, "52WeekChange": -0.21492535, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 2.63, "targetHighPrice": 30.0, "targetLowPrice": 8.0, "targetMeanPrice": 18.0, "targetMedianPrice": 17.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 30895000, "totalCashPerShare": 0.904, "ebitda": -31461000, "totalDebt": 1868000, "quickRatio": 4.476, "currentRatio": 4.57, "totalRevenue": 8000, "debtToEquity": 7.11, "revenuePerShare": 0.0, "returnOnAssets": -0.63282, "returnOnEquity": -1.3058299, "grossProfits": 8000, "freeCashflow": -10142000, "operatingCashflow": -21228000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -3962.0, "financialCurrency": "USD", "symbol": "GNLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_11172383", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.3346374, "regularMarketPrice": 2.63, "corporateActions": [], "postMarketTime": 1744920306, "regularMarketTime": 1744920002, "longName": "Genelux Corporation", "shortName": "Genelux Corporation", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1674743400000, "postMarketChangePercent": 0.0, "postMarketPrice": 2.63, "postMarketChange": 0.0, "regularMarketChange": 0.06000018, "regularMarketDayRange": "2.55 - 2.67", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 260340, "fiftyTwoWeekLowChange": 1.0300001, "fiftyTwoWeekLowChangePercent": 0.6437501, "fiftyTwoWeekRange": "1.6 - 5.885", "fiftyTwoWeekHighChange": -3.255, "fiftyTwoWeekHighChangePercent": -0.5531011, "fiftyTwoWeekChangePercent": -21.492535, "epsTrailingTwelveMonths": -0.95, "epsForward": -0.94, "epsCurrentYear": -1.0175, "priceEpsCurrentYear": -2.5847666, "fiftyDayAverageChange": -1.0586, "fiftyDayAverageChangePercent": -0.28699234, "twoHundredDayAverageChange": -0.19929981, "twoHundredDayAverageChangePercent": -0.07044139, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-01-26", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Genelux", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]